Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasone.
Cæcilie LedingJacob BodilsenChristian BrieghelZitta Barrella HarboeMarie HellebergClaire HolmSimone Bastrup IsraelsenJanne JensenTomas Oestergaard JensenIsik Somuncu JohansenStine JohnsenOle KirkBirgitte LindegaardChristian Niels MeyerRajesh MoheyLars PedersenHenrik NielsenStig Lønberg NielsenLars Haukali OmlandDaria PodlekarevaPernille RavnJonathan StarlingMerete StorgaardChristian SøborgOle Schmeltz SøgaardTorben TranborgLothar WieseSigne Heide Westring WormHanne Rolighed ChristensenThomas BenfieldPublished in: Infectious diseases (London, England) (2023)
Patients treated with remdesivir and dexamethasone had significantly improved outcomes compared to patients treated with standard of care alone. These effects were observed in most patient subgroups.